Overview

A Study of Tadalafil in Benign Prostatic Hyperplasia

Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the pharmacokinetics of tadalafil in Japanese and non-Japanese men with Benign Prostatic Hyperplasia (BPH). The safety of tadalafil will also be studied.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Tadalafil